Category: United States
-
Litigation funders are âcentralâ to class action regime, says UK Competition Appeal Tribunal chairman Hodge Malek KC
âWe donât want to kill off the industry [and] we want the best for everyone, including the funders,â Mr. Malek said at the 2nd Annual LF Dealmakers Europe in London yesterday.
-
ITC sides with ASUSTeK in wireless communications patent infringement dispute against Lenovo
The United States International Trade Commission has issued a final determination in a global patent dispute case between Lenovo and ASUSTek, upholding an Administrative Law Judge opinion that found the latter did not infringe three of Lenovoâs wireless communications and diagonal touchpad patents.
-
Patent-related complaints continue to dominate USITC Section 337 investigations
While the total number of Section 337 investigations dropped slightly in 2024, patent-related complaints continue to make up 88% of such ITC cases.
-
U.S. judge deprioritizes Samsung’s FRAND case against ZTE, UK judge requested post-hearing briefing on cross-jurisdictional implications
A federal judge in California has pushed back a hearing date by almost four months and a UK judge requested post-hearing briefing on Samsung’s multi-country FRAND lawsuits.
-
Federal Circuit decision in Optis v. Apple SEP case shows why UK courts should leave other jurisdictions alone: misconception exposed
In the seemingly neverending SEP story between Optis and Apple, the Federal Circuit has ordered a U.S. retrial on the merits and what would be a third damages trial in the same case.
-
Novartis and MSN settle part of chronic heart failure patent fight, but key patent remains
Novartis and MSN have settled one prong of their U.S. Entresto patent infringement dispute in the Federal Circuit, but the companies will continue to litigate over a second patent as Novartis strives to defend its corner of the chronic heart failure drug market.
-
Novo Nordisk lets key Ozempic patent lapse in Canada, despite being worldâs second-largest semaglutide market
Novo Nordisk has continued to pay for a key Ozempic patent in several jurisdictions across the world, and even obtained an adjusted expiration date in the U.S., but the company stopped paying fees in Canada as far back as 2018, records show.
-
Microsoft seeks declaratory judgment against Biogy over RFC one-time passcode patent in Northern District of California
Microsoft has alleged that Biogyâs prior âlitigation behaviorâ confirms it will be its next target in an RFC patent infringement suit.
-
USPTO on pace to quadruple discretionary denials under new interim procedures, report says
Recent data by Unified Patents has found that there were three times more United States Patent & Trademark Officeâs Patent Trial and Appeal Board discretionary denial decisions in Q1 2025 than the last record number of decisions (167 in 2020).
-
In U.S. court filing in ZTE case, Samsung raises “bias concerns” over Chinese FRAND proceedings: SEP-related sinophobia
Samsung just told a U.S. court it does not expect fairness from the Chinese courts because of the Chinese govenrment’s ownership position in ZTE.